Buy Ecstasy online in Koper

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buy Ecstasy online in Koper

In Ljubljana, the Association for Harm Reduction Stigma continues to distribute sterile injecting equipment. The mobile outreach service a van continues to operate in the central part of Slovenia. Injecting drug users have access to sterile injecting equipment but security measures are introduced: clients and staff have to keep 1. All other information and counselling are available via telephone or online. Drug testing, performed by Association Drogart , is open, but in smaller scale as before and with more safety measures. OST is working, users get their take home medicine for a week, some even for two or three weeks. OST delivery was organised in a very good way since the first indications that the epidemic can hit Europe appeared. One of the problems is closure of public transportation, which means that some persons cannot reach the OST clinics. For some of them, Association for harm reduction Stigma can deliver their methadone. The greatest challenge is to support homeless people because they have nowhere to go all daily care programs are closed, as well as public toilettes, due to safety reasons. There are negotiations with local authorities and ministries on how to deal with this situation. Night shelters and safe houses for women are still open. However, it is very problematic because staff and clients have no safety masks. The use of disinfectants is mandatory. The shelter in Ljubljana, run by the organisation Krali ulice , received new furniture. A special shelter for homeless people who may be infected with coronavirus is ready if this happens. Also, pink ecstasy pills and three other strong ecstasy pills with a very high content of MDMA have recently been detected in Ljubljana. That means that for a person who weighs 60 kg the dose is 60 — 90 mg. In quantities greater than mg, the possibility of complications due to MDMA ingestion is increased nausea, vomiting, cramping, restlessness and paranoia, severe motor disorders, headache, panic attack, high blood pressure, increased sweating, loss of consciousness, overheating of the body, etc. Users describe that 25B-NBOMe has a hallucinogenic effect already in very small quantities and is very difficult to use safely. They also present a number of side effects, such as: tongue and mouth, nausea, increased heart rate, high blood pressure, agitation, confusion, seizures, fever. A lot of cases of poisoning and fatalities are associated with substances from the group NBOMe. Therefore, extra prudence and compliance with the recommendations for harm reduction are recommended. Due to the likelihood that these pills will occur in other places around Slovenia and in neighbouring countries, users are advised to use them caution and contact anonymous testing service wherever available. The samples were collected at the info points of the DrogArt Association in Maribor and Ljubljana within the service of anonymous testing of psychoactive substances. We shall keep publishing these information. South East Europe is very connected region. We invite other our member organisations to share such information because they can be of use for others. Within the framework of the Early Warning System on new psychoactive substances NPS in Slovenia , fake xanax pills and cocaine with high levamisol content were detected in Ljubljana and Maribor. The results of the analysis, made in the National Laboratory for Health, Environment and Food, showed that the white rectangular tablet with a xanax sign the one discovered in Maribor is shown at the photo contains a substance called etizolam instead of alprazolam, while the one found in Maribor contains prometazin and ciproheptadin, medicines used for curing respiratory diseases. Etizolam belongs to the group of benzodiazepines and is used as an anti-insomnia and anxiety agent. Etisolam causes euphoria, relaxation, carelessness, and side effects are drowsiness, weakness and fatigue, poorer thinking ability and judgment, and loss of control of the body. When mixing with other drugs, the effects of the drug are exacerbated and the user can lose consciousness very quickly and stop breathing. This is the second known case of a false xanax pill — for the first time it detected in October this year. Levamisol is a veterinary drug used to treat parasitic infections. For humans, however, it can cause a decrease in the number of white blood cells and a bruising of the immune system, causing an individual to be at greater risk of developing dangerous infections. Both fake xanax and cocaine pills were purchased in November in Ljubljana from re-sellers. According to users, both substances are to be sold to a wider circle of people. Both samples were collected the info point of the Association DrogArt in Ljubljana and Maribor, through the anonymous drug testing programme. Due to the likelihood that such samples will occur in other places throughout Slovenia, caution of users is recommended and use the anonymous testing service. As the Xanax tablets are purchased on Dark net, this information may be of use to drug users and stakeholders in drug policy throughout the region. At doses higher than mg, the possibility of death overdose is greatly increased. Drogart advices 6 ways to decrease the possibility of complications when using pills: Always check which pill you have. Try to find as much information as possible about the content of the pill and effects for example, people who know this pill read current user reports and alerts on the Internet. But be careful — the same look does not necessarily mean the same content. Test the tablet before testing. Start with a quarter or at least a half and wait two hours to see what the effects are. If you decide to redisplay, be careful. This puts more and more burdens on the body, as well as negative effects. Do not mix with other drugs including alcohol , as this increases the likelihood of complications and overdoses. Drink enough liquid but not more than 0.

Sito Web Istituto Ortopedico Rizzoli

Buy Ecstasy online in Koper

These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format. All countries. Topics A-Z. The content in this section is aimed at anyone involved in planning, implementing or making decisions about health and social responses. Best practice. We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon. Explore our wide range of publications, videos and infographics on the drugs problem and how Europe is responding to it. All publications. More events. More news. We are your source of drug-related expertise in Europe. We prepare and share independent, scientifically validated knowledge, alerts and recommendations. About the EUDA. MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of nightlife and entertainment settings. On this page, you can find the latest analysis of the drug situation for MDMA in Europe, including prevalence of use, seizures, price and purity and more. European Drug Report — home. The drug situation in Europe up to Drug supply, production and precursors. Synthetic stimulants. Heroin and other opioids. New psychoactive substances. Other drugs. Injecting drug use in Europe. Drug-related infectious diseases. Drug-induced deaths. Opioid agonist treatment. Harm reduction. Reported use of the drug appeared to decline temporarily during periods of social distancing during the early phases of the COVID pandemic. The currently available data would, however, suggest an overall relatively stable level of consumption but with national variations in the recent trends observed and the caveat that overall supply side indicators are suggestive of a slight recent decline in availability. About half of the European cities reporting wastewater analysis found an increase in MDMA residues between and , although in most other cities some decline was noted. Overall, available indicators suggest that MDMA production continues within Europe, both for domestic consumption and for export to non-EU markets. The information available is strongly suggestive that most MDMA production continues to be largely concentrated in or around the Netherlands. There are some signs of a reduction in the volume being manufactured in the most recent data. An important caveat here is that this information mostly covers the first years of the pandemic and needs to be interpreted with caution. In addition, while overall the average MDMA content of tablets and purity of powders remained stable in , a recent decrease in the MDMA content of ecstasy tablets was noted in some important source countries, most notably the Netherlands. With a typical MDMA content of to milligrams, the overall strength of tablets available on the retail marketplace still remains high by historical standards. It is difficult to interpret the more recent data with any certainty, but a possible decline in production volumes and some reductions noted in MDMA tablet content may indicate that producers have experienced greater problems sourcing precursor chemicals or that some producers may have switched to producing other substances, either because of market demand or because they are more profitable. It may also reflect a perceived consumer demand for lower-strength products. The use of MDMA is rarely cited as a reason for entering drug treatment in Europe but acute poisonings and deaths are sometimes associated with the consumption of this substance. The use of MDMA therefore continues to represent an important issue for prevention and harm reduction messaging and interventions. The availability of higher strength products potentially increases the risk of adverse health outcomes associated with the consumption of this substance. Interestingly, a decline in MDMA-related presentations by a quarter was observed in sentinel hospital emergency departments with data for and This data set, however, is difficult to interpret in respect to overall trends, as it is not nationally representative, has limited coverage and may reflect either changes in consumption or reporting during the pandemic. While it is again difficult to generalise due to limitations in national and European coverage, the available information from drug checking services suggests that MDMA products are generally less subject to adulteration than other illicit drugs they screened in This does occur however, as illustrated by the inclusion of synthetic cathinones in MDMA tablets observed on some occasions. These sorts of mixtures may also increase the risk to consumers of experiencing unexpected adverse effects and potential harm. This data explorer enables you to view our data on the prevalence of MDMA use by recall period and age range. You can access data by country by clicking on the map or selecting a country from the dropdown menu. Prevalence data presented here are based on general population surveys submitted to the EMCDDA by national focal points. For the latest data and detailed methodological information please see the Statistical Bulletin Prevalence of drug use. Graphics showing the most recent data for a country are based on studies carried out between and Mean daily amounts of MDMA in milligrams per population. Sampling was carried out over a week in March and April Show source tables. Back to list of tables. Homepage Quick links Quick links. GO Results hosted on duckduckgo. Main navigation Data Open related submenu Data. Latest data Prevalence of drug use Drug-induced deaths Infectious diseases Problem drug use Treatment demand Seizures of drugs Price, purity and potency. Drug use and prison Drug law offences Health and social responses Drug checking Hospital emergencies data Syringe residues data Wastewater analysis Data catalogue. Selected topics Alternatives to coercive sanctions Cannabis Cannabis policy Cocaine Darknet markets Drug checking Drug consumption facilities Drug markets Drug-related deaths Drug-related infectious diseases. Recently published Findings from a scoping literature…. Penalties at a glance. Frequently asked questions FAQ : drug…. FAQ: therapeutic use of psychedelic…. Viral hepatitis elimination barometer…. EU Drug Market: New psychoactive…. EU Drug Market: Drivers and facilitators. Statistical Bulletin home. Quick links Search news Subscribe newsletter for recent news Subscribe to news releases. This make take up to a minute. Once the PDF is ready it will appear in this tab. Sorry, the download of the PDF failed. Table of contents Search within the book. Search within the book Operator Any match. Exact term match only. No overall trend emerges from the data on MDMA use. Of the 11 European countries that undertook surveys since and provided confidence intervals, 1 reported higher estimates than their previous comparable survey, 9 reported stable estimates and 1 reported a decrease. Seizures of MDMA precursors increased to 2. The Netherlands, however, reported a lower average MDMA content of ecstasy tablets mg per tablet. MDMA market in Europe. Table 2. Prevalence of drug use in Europe, trends Country Country code Geographical scope Substance Recall period Age Austria AT National Table 3. Masaryk Water Resesrch institute, p. Table 4. Table 5. Table 6. Table 7. Table 8. Table 9. Table Main subject. Target audience. Publication type. European Drug Report main page. On this page. Forensic Toxicology Labs. Prevalence data presented here are based on general populaton surveys submitted to the EMCDDA by national focal points.

Buy Ecstasy online in Koper